← Back to all trials
Active Not Recruiting
NCT07067632
Mortality Outcome of Controlled Blood Pressure Participants
Conditions: Valid MeSH Conditions, Hypertension (HTN)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 100
Sponsor: DejthidaNathaphong
Location: Nathaphong Bangkok
Summary
Despite advances in antihypertensive therapy, some patients with well-controlled blood pressure still experience fatal outcomes. This paradox raises critical questions about the efficacy of blood pressure-targeted interventions and whether BP control alone ensures survival. This systematic review and meta-analysis aims to evaluate all-cause mortality and cardiovascular death among hypertensive patients who achieved BP targets in RCTs or open-label trials.
To determine whether achieving controlled blood pressure through intentional intervention (pharmacological or procedural) in RCTs or open-label studies reduces mortality (all-cause and cardiovascular) in hypertensive patients.
Eligibility Criteria
Inclusion Criteria:
* Adults ≥18 years with diagnosed hypertension
Blood pressure controlled at target values defined by the study (e.g., \
Source: ClinicalTrials.gov (NCT07067632). StuddyBuddy aggregates publicly available trial information.